Lorenz Kevin has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 27322 shares of Fortress Biotech, Inc. ($FBIO) on January 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | Fortress Biotech, Inc. | $FBIO | Lorenz Kevin | Not found | A | common stock, par value $0.001 | 27322 | $0.00 | 101,009.0000 | 33,100,961 | 37.08% | 0.08% |
| Jan. 1, 2025 | Fortress Biotech, Inc. | $FBIO | Lorenz Kevin | Not found | A | common stock, par value $0.001 | 49383 | $0.00 | 73,687.0000 | 20,784,334 | 203.19% | 0.24% |
| Jan. 1, 2024 | Fortress Biotech, Inc. | $FBIO | Lorenz Kevin | Director | A | COMMON STOCK, PAR VALUE $0.001 | 3333 | $0.00 | 24,970.0000 | 8,110,906 | 15.40% | 0.04% |